Integrum AB (publ) (STO:INTEG.B)
10.60
0.00 (0.00%)
At close: Jan 16, 2026
Integrum AB Revenue
Integrum AB had revenue of 23.59M SEK in the quarter ending October 31, 2025, with 0.05% growth. This brings the company's revenue in the last twelve months to 102.58M, down -1.87% year-over-year. In the fiscal year ending April 30, 2025, Integrum AB had annual revenue of 97.52M, down -11.71%.
Revenue (ttm)
102.58M
Revenue Growth
-1.87%
P/S Ratio
2.72
Revenue / Employee
2.77M
Employees
39
Market Cap
278.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 97.52M | -12.94M | -11.71% |
| Apr 30, 2024 | 110.46M | 32.91M | 42.44% |
| Apr 30, 2023 | 77.55M | 16.72M | 27.50% |
| Apr 30, 2022 | 60.82M | 17.02M | 38.87% |
| Apr 30, 2021 | 43.80M | 16.19M | 58.62% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |